ePrints

A phase I dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in patients with advanced solid tumours

Lookup NU author(s): Professor Ruth Plummer, Rebecca Perrett, Professor Alan Calvert

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Shaw H, Plummer ER, Vidal L, Perrett RH, Pilkington M, Temple G, Fong P, Amelsberg A, Calvert AH, de Bono J

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 42nd Annual Meeting of the American Society of Clinical Oncology

Year of Conference: 2006

Pages: 127S

ISSN: 0732-183X

Publisher: Journal of Clinical Oncology, American Society of Clinical Oncology

Notes:

Library holdings: Search Newcastle University Library for this item

ISBN: 15277755

Share